secwatch / observer
8-K filed December 12, 2022, 6:59 PM ET ticker CIMG CIK 0001527613
other material confidence high sentiment neutral materiality 0.50

NuZee shareholders approve reverse stock split; second proposal fails

CIMG Inc.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

CIMG Inc. shareholders rejected Amendment of Articles of Incorporation to Reincorporate the “Additional Articles” at the 2022-12-09 meeting.

Proposal
charter amendment
Outcome
failed
Meeting
2022-12-09
Exact text from the filing
Proposal Two – Amendment of Articles of Incorporation to Reincorporate the “Additional Articles” Votes For: 8,709,661 Votes Against: 102,457 Abstain: 23,012 Broker Non-Votes: 6,389,637
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

CIMG Inc. shareholders approved Amendment of Articles of Incorporation to Effect a Reverse Stock Split at the 2022-12-09 meeting.

Proposal
reverse split
Outcome
passed
Meeting
2022-12-09
Exact text from the filing
Proposal One – Amendment of Articles of Incorporation to Effect a Reverse Stock Split Votes For: 14,864,742 Votes Against: 352,547 Abstain: 7,478
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

CIMG Inc. shareholders approved Adjournment of Special Meeting to a Later Date or Dates to Solicit Additional Proxies if Necessary at the 2022-12-09 meeting.

Outcome
passed
Meeting
2022-12-09
Exact text from the filing
Proposal Three – Adjournment of Special Meeting to a Later Date or Dates to Solicit Additional Proxies if Necessary Votes For: 14,378,753 Votes Against: 836,050 Abstain: 9,964
View on SEC.gov

1179 shareholder votes filed in the last 30 days. Browse all shareholder votes →

CIMG Inc. filing history →

Source: SEC EDGAR
accession 0001493152-22-035168
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.